HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories on Friday announced the U.S. launch of its generic of AbbVie’s Prometrium (progesterone) capsules.
The Dr. Reddy’s progesterone capsules — recently approved by the Food and Drug Administration — will be available in 100- and 200-mg dosage strengths. According to QuintilesIMS data, brand and generic sales for the product had U.S. moving annual total sales of $153 million for the 12 months ended February 2017.
The capsules will be available in 100-count bottles.
April 24, 2017 | By David Salazar